.jetcityimage/iStock Content using Getty Images Morgan Stanley has selected Eli Lilly (NYSE: LLY) as its own best biopharma selection for 2025 as well as ranked yet another 9 labels in the space as over weight. The financial investment bank pointed out in a keep in mind that it remains to strongly believe “diabesity is actually set to end up being.